The crisis in the Russian pharmaceutical sector is deepening as the country’s Ministry of Health has officially called on the regions to form a four-month reserve of drugs, which is mainly due to the possible interruptions in their supplies from abroad, reports The Pharma Letter’s local correspondent.
Despite the fact that most global drugmakers continue supplies of their drugs to Russia, which has had Western sanctions imposed on it following its invasion of Ukraine, it has become more difficult for them to do so.
In order to prevent any possible shortages the Russian Ministry of Health has given strict instructions to all the regions of the country to form a sufficient amount of the drugs - at least four months of stock.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze